EFFECT OF REIMBURSEMENT POLICY ON VISUAL OUTCOMES IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH RANIBIZUMAB. [electronic resource]
Producer: 20210827Description: 2191-2197 p. digitalISSN:- 1539-2864
- Adult
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Diabetic Retinopathy -- drug therapy
- Female
- Fluorescein Angiography
- Health Policy
- Humans
- Intravitreal Injections
- Macular Edema -- drug therapy
- Male
- Middle Aged
- National Health Programs
- Ranibizumab -- therapeutic use
- Reimbursement Mechanisms
- Retrospective Studies
- Subretinal Fluid
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.